Authors

Zuranolone Offers New Hope for Postpartum Depression

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Oncology Overview: Investigational Autologous TIL Immunotherapy LN-145 for Cervical Cancer

Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.

Cognitive Impairment, Frailty Reframe CVD Care in Older Adults

New ACC statement urges pharmacists to weigh cognition and frailty in every older adult's cardiovascular regimen.

Overcoming Failure as a Recent Pharmacy Graduate

Failing is not final, and it does not define what kind of pharmacist or resident a student can be.

Pharmacists and Providers: Key Collaborators in the Shift Toward Decentralized and Virtual Health Care

Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.

Biosimilars: A Guide for Pharmacists

Given the growing market availability and current underutilization of biosimilars, pharmacists must possess a comprehensive understanding of these agents to effectively advocate for their adoption.

Topiramate’s Emerging Role in Cocaine Use Disorder

Topiramate, an antiseizure medication, has an off-label indication for cocaine use disorder and it received a conditional recommendation with a low certainty of evidence.

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

Biosimilars: A Guide for Pharmacists

Given the growing market availability and current underutilization of biosimilars, pharmacists must possess a comprehensive understanding of these agents to effectively advocate for their adoption.

In Mississippi’s Maternal Health Crisis, Pharmacies Become Lifelines

The Medications Optimizing Maternal Safety (MOMS) program offers vital support to pregnant patients through community pharmacies.

The Role of the Pharmacist in the Management of Psychosis in Parkinson Disease

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy

Op-Ed: Cannabis Policy Needs Pharmacists

Canada’s experience demonstrates the risks of sidelining pharmacy in medical cannabis policy.

FGFR Inhibitors for Treatment of Primary CNS Tumors

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Reduced POMP Dosing Shows Comparable Efficacy in ALL Maintenance

Arefa Bacchus, PharmD, shared key insights about the use of POMP therapy in patients with acute lymphoblastic leukemia (ALL).

Optimizing Biomarker Testing in NSCLC to Expand Targeted Treatment Options

Pharmacists can help standardize biomarker testing and improve access to targeted therapies in non–small cell lung cancer.

Opinion: To Succeed, Direct-to-Patient Drug Sales Will Require Better Technology

High-Risk, Low-Benefit Treatments for Chronic Low Back Pain Demand Reevaluation

In an interview with Pharmacy Times, Caitlin Jones, PhD, discusses why high-risk, low-benefit treatments for chronic low back pain require greater scrutiny.

Sibeprenlimab-szsi for Primary IgA Nephropathy: A New Drug Review

Sibeprenlimab, a new APRIL blocker, cuts proteinuria in IgA nephropathy.

What the Metrics Don't Measure

Pharmacists quietly prevent medication harm, ease discharge chaos, and manage rising health care strain through unseen cognitive work.

Specialty Pharmacy Technicians in Oncology Transitions of Care: An Untapped Workforce Resource

Specialty pharmacy technicians address barriers in oral anticancer therapy and transitions of care through improved care coordination and therapy access.

Respiratory Syncytial Virus in Older Adults: Research Insights and Recommendations

Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.

Revolutionizing Treatment with Bispecific Therapies: Navigating the Challenges Ahead

By decade’s end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.

Pharmacy Fellowship Survival Guide: Work-Life Balance, Wellness, and Time Management Strategies

How to thrive professionally and personally during pharmacy fellowship

Preserving Access to Preventive Care Amid a Changing Health Care Environment

Community pharmacists are crucial in Increasing immunization rates, addressing access barriers, and supporting evidence-based immunization guidance.

A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance Reports

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.

Re-adding EXPAREL to Formulary: The Pharmacist Perspective

This article is sponsored by Pacira Pharmaceuticals, Inc.

From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes

Explore the rising prevalence of diabetes in the US, its various types, and the critical role pharmacists play in patient care.

The Evolving Role of Pharmacovigilance in Digital Therapeutics

Digital therapeutics (DTx), a novel evidence-based software approach, is revolutionizing health care by delivering personalized treatments. Pharmacovigilance ensures DTx safety but faces challenges such as data privacy and standardization.